Published in Eur Heart J on December 20, 2007
Aortic dilation in bicuspid aortic valve disease: flow pattern is a major contributor and differs with valve fusion type. Circ Cardiovasc Imaging (2013) 3.04
Hemodynamic predictors of aortic dilatation in bicuspid aortic valve by velocity-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 1.33
Surgical treatment of bicuspid aortic valve disease: knowledge gaps and research perspectives. J Thorac Cardiovasc Surg (2014) 1.08
Mechanism of aortic medial matrix remodeling is distinct in patients with bicuspid aortic valve. J Thorac Cardiovasc Surg (2013) 1.08
Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome. BMC Med Genet (2014) 0.98
The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity. Ann Cardiothorac Surg (2013) 0.97
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry. J Am Coll Cardiol (2016) 0.87
Bicuspid aortic valve syndrome: heterogeneous but predictable? Eur Heart J (2008) 0.84
Progressive aortic dilation and aortic stiffness in children with repaired tetralogy of Fallot. Heart Vessels (2013) 0.83
Genetically alike Syrian hamsters display both bifoliate and trifoliate aortic valves. J Anat (2011) 0.83
Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve. Heart Vessels (2011) 0.83
Augmentation index and aortic stiffness in bicuspid aortic valve patients with non-dilated proximal aortas. BMC Cardiovasc Disord (2013) 0.81
Bicuspid aortic valve: inter-racial difference in frequency and aortic dimensions. JACC Cardiovasc Imaging (2012) 0.79
Aortic stiffness and left ventricular diastolic function in children with well-functioning bicuspid aortic valves. Eur Heart J Cardiovasc Imaging (2015) 0.77
Evaluation of myocardial strain and artery elasticity using speckle tracking echocardiography and high-resolution ultrasound in patients with bicuspid aortic valve. Int J Cardiovasc Imaging (2016) 0.76
Pulse wave velocity involving proximal portions of the aorta correlates with the degree of aortic dilatation at the sinuses of valsalva in ascending thoracic aortic aneurysms. Ann Vasc Dis (2014) 0.76
Echocardiography in the evaluation of athletes. F1000Res (2015) 0.75
Another piece in the puzzle of bicuspid aortic valve syndrome. Eur Heart J Cardiovasc Imaging (2016) 0.75
Characteristics of Carotid Artery Structure and Mechanical Function and Their Relationships with Aortopathy in Patients with Bicuspid Aortic Valves. Front Physiol (2017) 0.75
A unique aortic arterial meshwork with a major aortopulmonary collateral artery, a major arteriovenous collateral artery, and a coronary arteriovenous fistula in a young man with a bicuspid aortic valve. Pediatr Cardiol (2012) 0.75
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA (2006) 5.79
A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med (2009) 4.54
Arrhythmogenic right ventricular cardiomyopathy. Lancet (2009) 4.46
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res (2005) 3.99
Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm (2004) 3.54
Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol (2003) 3.52
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J (2004) 3.45
Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med (2008) 3.30
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2002) 2.95
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm (2009) 2.82
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation (2006) 2.81
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J (2007) 2.76
Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J (2005) 2.56
Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation (2003) 2.56
Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J (2009) 2.37
The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int (2003) 2.22
Myocardial edema underlies dynamic T-wave inversion (Wellens' ECG pattern) in patients with reversible left ventricular dysfunction. Heart Rhythm (2011) 2.18
Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation (2003) 2.12
Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. Heart Rhythm (2011) 2.11
Concealed metastatic lung carcinoma presenting as acute coronary syndrome with progressive conduction abnormalities. Circulation (2012) 2.10
Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol (2008) 2.09
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol (2008) 2.06
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J (2008) 2.05
Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm (2009) 2.00
Decision making in elderly patients with severe dementia and pneumonia. Int J Geriatr Psychiatry (2010) 1.94
Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes (2003) 1.92
Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol (2004) 1.82
Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet (2013) 1.81
Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch (2007) 1.81
Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis (2007) 1.64
Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (2010) 1.62
Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol (2008) 1.62
Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J (2009) 1.59
Scimitar syndrome: a European Congenital Heart Surgeons Association (ECHSA) multicentric study. Circulation (2010) 1.59
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2010) 1.58
Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates. Hum Pathol (2005) 1.57
Prevalence rate and correlates of depressive symptoms in older individuals: the Veneto Study. J Gerontol A Biol Sci Med Sci (2002) 1.56
Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J (2006) 1.56
Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol (2002) 1.54
Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm (2007) 1.51
Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol (2013) 1.49
Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study. Atherosclerosis (2011) 1.48
Strategies for the prevention of sudden cardiac death during sports. Eur J Cardiovasc Prev Rehabil (2011) 1.48
Host-derived circulating cells do not significantly contribute to cardiac regeneration in heterotopic rat heart transplants. Cardiovasc Res (2005) 1.48
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation (2006) 1.48
Sudden coronary death--not always atherosclerotic. Heart (2010) 1.47
Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test? Heart Rhythm (2012) 1.47
Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation (2005) 1.47
T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol (2014) 1.45
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. J Alzheimers Dis (2011) 1.45
Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail (2009) 1.44
The effects of weight changes after middle age on the rate of disability in an elderly population sample. J Am Geriatr Soc (2009) 1.44
Spontaneous coronary artery dissection mimicking aortic dissection. Cardiovasc Pathol (2004) 1.42
Esophagitis in frail elderly people. J Clin Gastroenterol (2007) 1.41
End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septum. Heart Rhythm (2012) 1.40
Unexplained syncope, Brugada-like ECG and minimal structural right ventricular abnormalities: which is the right diagnosis? J Cardiovasc Med (Hagerstown) (2009) 1.39